AAHI, also known as The Access to Advanced Health Institute, is a pioneering brand that is committed to developing platforms for next-generation vaccines and immunotherapies. Their mission is to address real-world needs by providing powerful prophylactic and therapeutic solutions. AAHI leverages its expertise in RNA and adjuvant formulations to drive innovation in vaccine development.

They offer in-house manufacturing, formulation, and product development services, enabling them to develop effective solutions. Their platform technology facilitates rapid vaccine and immunotherapy development, ensuring that life-enhancing products are accessible globally. With a focus on global equity, AAHI collaborates with various partners and forges collaborations to make immunologic innovations accessible to those who need them the most.

Their expertise in RNA vaccines and adjuvant formulations allows for revolutionary development of potent and durable vaccines that are commercially scalable and accessible across diverse regions. Based in Seattle, Washington, AAHI is dedicated to protecting and improving people's health around the world through collaboration and innovation